Editor in Chief @BioCentury. Dr, the Ph.D-type. Biotech innovation & breaking barriers, one woman at a time. Views are mine, hope to make them yours too.
Bay Area CA
Joined January 2012
- Tweets5.3K
- Following1.2K
- Followers3.2K
- Likes6.3K
Simone Fishburn 🎗️ retweeted
Our Co-Founder, Chairman and CEO, @johnvoyler, recently joined @FishburnSimone on the @BioCentury podcast. They delved into BeiGene's corporate global growth and our innovative pipeline. Tune in to the show to discover more: bit.ly/4ez5BH4
Simone Fishburn 🎗️ retweeted
The value in mapping genetics to the medical phenome: case studies from @VanderbiltU. Nancy Cox discusses insights from longitudinal EHRs, biobank data, and their value to drug developers: a BioCentury Q&A buff.ly/3ZDWUaA
Simone Fishburn 🎗️ retweeted
John Oyler’s long game at @BeiGeneGlobal: Owning the process from clinical trials to manufacturing. The oncology company's CEO sits down with BioCentury Editor in Chief @FishburnSimone to talk company building and what's next for BeiGene buff.ly/3MRnLYR
Simone Fishburn 🎗️ retweeted
We’re inspired by @Immunoplayers in his fireside chat about our joint Together for CHANGE initiative to address data and workforce gaps: "This is a dream project to bring together everyone — all pharma, academic partners are invited to join… First we have to build that trust."
Simone Fishburn 🎗️ retweeted
RGC’s Gonçalo Abecasis lent his insights during an enlightening panel discussion at @BioCentury Grand Rounds on optimizing data for purpose. He shared that at RGC, “We are big believers that genetic variation leads to good therapies.” #BioCenturyGrandRounds 🧬
Simone Fishburn 🎗️ retweeted
This Harvard student speaks the truth. “Zionist” is not a slur. @Harvard students need to stop using it as one. @thecrimson thecrimson.com/article/2024/…
Simone Fishburn 🎗️ retweeted
Introducting BioCentury's Back to School 2024. Editor in Chief @FishburnSimone and colleagues drill down on picking the right target, and ask can industry solve its biggest bottleneck? buff.ly/4gieu9K
Simone Fishburn 🎗️ retweeted
What a heart-wrenching presentation at the DNC by the parents of Hersh Goldberg-Polin, the young hostage currently being held by Hamas in Gaza.
"There is a surplus of agony on all sides of the tragic conflict in the Middle East. In a competition of pain, there are no winners."
Simone Fishburn 🎗️ retweeted
Building up B cells @Biogen — Jane Grogan discusses her plans for research at the biotech with @FishburnSimone on The #BioCenturyShow buff.ly/3WFM14I
Simone Fishburn 🎗️ retweeted
In an exclusive conversation with @BioCentury, Jim Wilson describes how he plans to use newly launched GemmaBio as a vehicle to create a sustainable model for ultrarare disease gene therapies by capitalizing on efficiencies gained from a platform model. biocentury.com/article/65318…
Simone Fishburn 🎗️ retweeted
Greg Verdine, Co-Founder, President & CEO of LifeMine Therapeutics and Professor of Chemistry at Harvard University is joining #BioCenturyGrandRounds to deliver a keynote address: Blowing up the small molecule paradigm.
Learn more: loom.ly/yydzbC8
Simone Fishburn 🎗️ retweeted
How did @AstraZeneca turn around its oncology R&D to become a leader in the field? @FishburnSimone talks to @susanmgalbraith, $AZN's head of oncology, about how they inculcated a new environment for decision-making. Part 1 of a 2-part Q&A. buff.ly/4bTMKF7
Simone Fishburn 🎗️ retweeted
Thanks @steveusdin1 for having me on The @BioCentury Show this week! Listen here: biocentury.com/article/65293…
Simone Fishburn 🎗️ retweeted
BioCentury's Editor in Chief @FishburnSimone joined @TheMilnerInst's Therapeutics Symposium to discuss the explosion of new modality drugs coming to market, and the value of academic-biotech partnerships in diagnostics and infectious disease research.
We were thrilled to host our Pitch Day and Symposium last week! What were your key takeaways?
👉Read an overview from the Symposium and Pitch Day here: milner.cam.ac.uk/milner-inst…
👉View the first selection of photographs here: milner.cam.ac.uk/milner-ther… 👀
#MilnerSymp24
Simone Fishburn 🎗️ retweeted
BioCentury invites you to attend its Grand Rounds event in Nashville this September to engage with thought leaders at the academia/industry interface. Register before August 2 to access the advanced discount. Learn more: bit.ly/3L16hsm
Simone Fishburn 🎗️ retweeted
In a BioCentury Editor's Commentary, Washington Editor @SteveUsdin1 argues that @US_FDA approval of @Sarepta's gene therapy exposed management failures. $SRPT buff.ly/3KWG79R
Simone Fishburn 🎗️ retweeted
Last chance to register for #MilnerSymp24! Don't miss:
🤩 Steve Jackson, @CRUK_CI
🤩 Todd Golub, @broadinstitute
🤩Sarah Teichmann, @SCICambridge
🤩 Jill Richardson, MSD
🤩 Simone Fishburn, @BioCentury
🤩 Dave Hallett, @Exscientia
👉 milner.cam.ac.uk/milner-ther…
Simone Fishburn 🎗️ retweeted
REALLY enjoyed my discussion with @steveusdin1 for @BioCentury (tinyurl.com/46xyhna4)
#H5N1 is at our doorstep, closer to humans than it has ever been before. Are we ready? What more should be done to be better prepared? If this doesn't ignite, steps we take now will serve as an important exercise.
Avian flu has jumped from birds to cows to humans. The U.S. is flying blind @RickABright warns. It is either the start of a serious outbreak or a fire drill. Either way, the U.S. needs to do much better. Watch at tinyurl.com/46xyhna4 or listen at tinyurl.com/46xyhna4
Simone Fishburn 🎗️ retweeted
U.S. flunking pandemic fire drill: Former BARDA Director Rick Bright warns U.S. isn’t taking steps to counter possible H5N1 outbreak. Bright in conversation with BioCentury's @SteveUsdin1 buff.ly/3z4uds8
Simone Fishburn 🎗️ retweeted
Check out my latest article: Debating a new pathway for ultrarare linkedin.com/pulse/debating-… via @LinkedIn
